The AMD Center

Filter Your Results

 

News

 

Results of the AREDS 2 Study

Srinivas R. Sadda, MD, shares the results of the AREDS 2 Study, which tested an updated formulation of the AREDS nutriti…

SriniVas Sadda, MD

Effects of Switching AMD Patients to Aflibercept

Ted Leng, MD, reviews the visual acuity and anatomic outcomes of eyes with age-related macular degeneration that were sw…

Ted Leng, MD

HARBOR 2 Results Support Individualized Dosing in Patients w…

Brandon Busbee, MD, discusses the HARBOR 2 study results, focusing on how the results support individualized dosing in p…

Brandon G. Busbee, MD

Implantation of Intraocular Mirror Telescope Implant as Ante…

Isaac Lipshitz, MD, evaluated the efficacy of a newly designed mirror telescopic implant (X2.5 Mag) for improving the vi…

Isaac Lipshitz, MD

Endpoint Management and PASCAL Laser Systems: Less-Damaging …

Pravin Dugel, MD, ophthalmologist at Retinal Consultants of Arizona, discusses the shift in the use of lasers for the tr…

Pravin U. Dugel MD

Wet AMD Case Presentation II

Moderator: Kourous Rezaei, MD Panel: Bob Avery, MD, Jay S. Duker, MD, SriniVas Sadda, MD

Wet AMD Case Presentation III

Moderator: Kourous Rezaei, MD Panel: Bob Avery, MD, Jay S. Duker, MD, SriniVas Sadda, MD

Wet AMD Case Presentation I

Moderator: Kourous Rezaei, MD Panel: Bob Avery, MD, Jay S. Duker, MD, SriniVas Sadda, MD

 

This Month's Supplements

 
 

Contact Info

Bryn Mawr Communications LLC
1008 Upper Gulph Road, Suite 200
Wayne, PA 19087

Phone: 484-581-1800
Fax: 484-581-1818

Scott Krzywonos
Editor-in-Chief
484-581-1880
skrzywonos@bmctoday.com

Janet Burk
Publisher
214-394-3551
jburk@bmctoday.com

About Retina Today

Retina Today is a publication that delivers the latest research and clinical developments from areas such as medical retina, retinal surgery, vitreous, diabetes, retinal imaging, posterior segment oncology and ocular trauma. Each issue provides insight from well-respected specialists on cutting-edge therapies and surgical techniques that are currently in use and on the horizon.